New York, New Jersey Clinical Trials

A listing of New York, New Jersey clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 416 clinical trials
Clindamycin and Triamcinolone in People With Glioblastoma to Prevent Skin-Related Side Effects of Tumor Treating Fields

The participants are being treated with Tumor Treating Fields (TTFields) for malignant glioma, and this type of treatment may cause skin-related side effects. This study will test whether using clindamycin and triamcinolone topical lotions can prevent skin-related side effects of TTFields.

tumor treating fields therapy
ttfields
triamcinolone topical
glioma
glioblastoma multiforme
Memorial Sloan Kettering Cancer Center
 (3.2 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +6 other locations
Vemurafenib Plus Copanlisib in Radioiodine-Refractory (RAIR) Thyroid Cancers

The purpose of this study is to develop a new drug treatment to reverse tumor resistance to radioiodine in BRAF mutant tumors so that radioiodine can be given to shrink tumors. This study is also being done to find out the highest doses of copanlisib and vemurafenib that, when given …

lipase
thyroid cancer, follicular
pet/ct
primary tumor
carcinoma
Memorial Sloan-Kettering Cancer Center (All protocol activities)
 (3.1 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +6 other locations
THE ALIGN-AR PIVOTAL TRIAL: JenaValve Pericardial TAVR Aortic Regurgitation Study

To collect information about treatment for symptomatic severe Aortic Regurgitation (AR), which affects the aortic valve in the heart. Aortic regurgitation is a condition where aortic valve in the heart does not close tightly and allows some blood to leak back into the heart chamber. Symptoms of aortic regurgitation may …

shortness of breath
aortic valve replacement
regurgitation
fatigue
New York-Presbyterian/ Columbia University Medical Center
 (5.1 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +9 other locations
Adenosine Receptor Antagonist Combination Therapy for Metastatic Castrate Resistant Prostate Cancer

This is a Phase 1b/2, open-label, multicenter platform trial to evaluate the antitumor activity and safety of AB928-based combination therapy in participants with metastatic castrate resistant prostate cancer (mCRPC).

castration-resistant prostate cancer
taxane
docetaxel
combined modality therapy
prostatic neoplasms, castration-resistant
New York University, Langone Health
 (3.3 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +21 other locations
A Study of Hydroxychloroquine vs Placebo to Prevent COVID-19 Infection in Patients Receiving Radiotherapy

The researchers are doing this study to find out whether the study drug hydroxychloroquine can prevent infection with the COVID-19 virus, compared with placebo, in people who are receiving radiation therapy for their cancer. The placebo used in this study is a tablet that looks the same as the study …

systemic therapy
skin cancer
serologic test
acute respiratory syndrome (sars)
antigen test
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
 (3.1 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +6 other locations
Study of PSMA PET/MR Guided Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost (SBRT-SIB) for High-Intermediate and High Risk Prostate Cancer

This is a single-arm Phase II clinical trial assessing the clinical efficacy of prostate specific membrane antigen (PSMA) PET/MR guided MR-LINAC based SBRT-SIB with planned accrual of 50 patients.

stereotactic body radiation therapy
adenocarcinoma
hbed-cc
adenocarcinoma of prostate
metastasis
Weill Cornell Medicine
 (3.1 away) Contact site
  • 16 views
  • 19 Feb, 2024
  • 1 location
Self-Control in Bulimia Nervosa

This study examines the influence of acute fasting and eating on self-control in adult females with and without bulimia nervosa (BN). Specifically, the study team is investigating whether differences in behavior and brain activation in response to computer tasks after fasting and after eating a meal could help to explain …

bulimia
fasting
MRI
Center of Excellence in Eating and Weight Disorders at the Icahn School of Medicine at Mount Sinai
 (3.6 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
A Study of CC-98633 BCMA-targeted Chimeric Antigen Receptor (CAR) T Cells in Subjects With Relapsed and/or Refractory Multiple Myeloma

This is a Phase 1, multicenter, open-label study of CC-98633, BCMA-Targeted NEX-T Chimeric Antigen Receptor (CAR) T Cells, in subjects with relapsed and/or refractory multiple myeloma. The study will consist of 2 parts: dose-escalation (Part A) and dose-expansion (Part B). The dose-escalation part (Part A) of the study is to …

daratumumab
multiple myeloma
pomalidomide
carfilzomib
measurable disease
Memorial Sloan Kettering Cancer Center
 (3.1 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +8 other locations
Using Advanced Imaging Studies to Develop a Profile of High-grade Serous Ovarian Cancer

The researchers are doing this study to find out whether the researchers can combine information provided by PET/MRI scans with information from tests on blood and tissue samples to develop a very detailed description (profile) of high-grade serous ovarian carcinoma (HGSOC), which could improve our ability to treat this disease. …

ovarian carcinoma
ovarian cancer
cancer
carcinoma
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
 (3.1 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry

The ICGG Gaucher Registry is an ongoing, international multi-center, strictly observational program that tracks the routine clinical outcomes for patients with Gaucher disease, irrespective of treatment status. No experimental intervention is involved; patients in the Registry undergo clinical assessments and receive care as determined by the patient's treating physician. The …

imiglucerase
deficiency
gaucher disease
eliglustat
Investigational Site Number 840040
 (3.3 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +220 other locations